Read + Share
Panaccione R, Colombel JF, Travis SPL, Bossuyt P, et al. Tight control for Crohn's disease with adalimumab-based treatment is
cost-effective: an economic assessment of the CALM trial. Gut 2020;69:658-664.
PMID: 31285357
|
 |
|
Panaccione R, Colombel JF, Travis SPL, Bossuyt P, et al. Tight control for Crohn's disease with adalimumab-based treatment is
cost-effective: an economic assessment of the CALM trial. Gut 2020;69:658-664.
PMID: 31285357
|
|
|
|